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Purpose: The performance ofa graft created from the upper arm basilic and cephalic veins 
in continuity was investigated. 
Methods: Retrospective analysis of 50 patients, who underwent 54 distal reconstructions 
with an upper arm vein loop graft between February 1989 and October 1993 
(male-to-female ratio of 30/20; mean age of 69.2 years, range 39 to 87; 74% had diabetes) 
was undertaken. Vein grafts were harvested through a near continuous incision, leaving 
a skin bridge in the cubita. Intraoperative angioscopy was used to exclude ndoluminal 
disease and to directly observe valvulotomy of the nonreversed part of the graft. 
Results: Operations were performed for limb salvage in 98.2% of 17 primary and 37 
reoperative procedures. Eleven femoropopliteal, 33 femorotibial-pedal, seven popliteal- 
distal, and two outflow jump grafts were performed. The ipsilateral saphenous vein was 
unavailable because of previous infrainguinal bypass in 35, coronary artery bypass grafting 
in 14, and unsuitable quality in 5 cases. Thirty.eight grafts were used in continuity, and 
16 grafts required repair or splicing with additional vein segments. Primary 30-day 
patency rate was 92.6% (n = 4 occlusions). No operative deaths occurred. The cumulative 
patency rate at 1 year was 74.4%, the limb salvage rate 90.7%. 
Conclusions: The upper arm vein loop is a durable graft with excellent short-term and 
midterm patency rates. Sufficient vein length can be obtained to reach the below-knee and 
midtibial levels. Angioscopic quality assessment is a valuable adjunct to exclude 
endoluminal disease most commonly occurring in the median cubital vein. Straightening 
the curve of the median cubital vein and val~xtlotomy donot influence patency rates. This 
is a valuable technique for vascular surgeons that enables rescue of ischemic limbs under 
otherwise difficult circumstances. (J VASC SURG 1995;21:586-94.) 
Distal arterial revascularization in the absence of 
an adequate saphenous vein is a challenging problem 
in vascular surgery. With aggressive r vascularization 
policies the saphenous vein becomes less often 
available for distal bypass after previous use for 
coronary artery bypass or distal revascularization 
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procedures. Previous reports how that up to 40% of 
patients requiring revascularization of  the lower 
extremity do not possess an adequate ipsilateral 
saphenous vein) Results with prosthetic onduits 
have been shown to be promising in the femo- 
ropopliteal level but do perform less favorably for 
tibial and pedal reconstructions or redo proce- 
dures. 2,3 Alternative vein sources for autologous 
reconstruction are limited. Consideration has to be 
given to the ease with which the vein is harvested, as 
well as diameter and availability of  the conduit. As 
alternative autologous conduits, the use of the 
contralateral saphenous vein, 4 the superficial femoral 
vein, 5 or the lesser saphenous vein 6,7 and the arm 
veins 8~3 has been advocated. It is often difficult to 
obtain sufficient graft length to reach midtibial or 
even more distal evel, and splicing of  vein segments 
of different origin may be necessary. 1'4 Arm veins 
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Table I. Patient characteristics of 50 
patients who underwent 54 upper arm vein 
loop graft procedures for distal 
bypass reconstruction 
Patients 
No. 50 
SexM:W 30:20 
Age (range) 69.2 (39-86) 
Diabetes (%) 37 (74%) 
Procedures 
No. 54 
Limb salvage (%) 98.1 
Primary I7 
Redo 35 
Revision 2 
Table II. Indication for the use of the 
upper arm vein loop graft and availability of 
the contralateral saphenous vein as an 
alternative autogenous conduit 
Ipsilateral Contralateral 
Unavailable 49 34 
Previous infrainguinal bypass 35 26 
Previous harvest for CABG 14 5 
Other reasons ~ - 3 
Available 5 20 
Unsuitable vein 5 - 
Total 54 54 
CABG, Coronary artery bypass graft. 
~See text. 
have been used as an alternative conduit successfully 
since 1969. 8 Most commonly the cephalic vein from 
the wrist to the deltopectoral groove, providing 
sufficient graft length, is used. The forearm portion of 
the vein can be scarred or of small diameter, making 
this part of the vein unsuitable for grafting. A 
combined basilic-cephalic upper arm vein graft pro- 
vides additional graft length for distal reconstruction, 
even in the presence of unusable forearm veins. This 
type of graft was first described by LoGerfo et a1.14 in 
1987 and, subsequently, by other authors. 15 The 
introduction of angioscopy as a highly accurate tool 
to evaluate graft quality led to recognition of the high 
number of endoluminal bnormalities and damaged 
vein segments in arm veins. 16 With the possibility to 
"upgrade" inferior vein segments under direct vision, 
arm veins finally became a highly reliable source of 
constant quality for autologous grafting.I7 Herein we 
report our experience in 54 consecutive r construc- 
tions and the impact of angioscopic monitoring in 
the use of upper arm cephalic-basilic loop graft since 
1989. 
PATIENTS AND METHODS 
A consecutive series of patients, undergoing 
surgery for infrainguinal bypass for arterioocclusive 
disease with a basilic-cephalic upper arm vein loop 
graft between January 1989 and October 1993, was 
included in this retrospective series. All hospital 
charts, operation otes, and intraoperative angios- 
copy reports were reviewed according to a fixed 
protocol. Follow-up data were collected from hospi- 
tal records and outpatient charts from the individual 
surgeons. 
The configuration and harvest of the partially 
reversed-nonreversed upper arm vein loop graft has 
been described by LoGerfo et ai)4 In brief, the vein 
is exposed through a continuous incision on the 
medial and lateral aspect of the upper arm. A skin 
bridge at the cubital fossa is left whenever possible. 
Attention has to be taken to preserve the branches of 
the medial antebrachial cutaneous nerve, which 
crosses the vein at its entrance into the subfascial 
layer. The vein is followed to the junction with the 
brachial or axillary vein. This junction can be variable, 
but it is usually located in the axillary groove. The 
cephalic vein is dissected up to the deltopectoral 
groove and is divided at its junction with the deep 
venous ystem. A tributary of the median cubital vein 
or the forearm cephalic vein is left long as an access 
for the valvulotome or for possible use as an onlay 
patch for the median cubital vein. The vein is handled 
with great care and gently dilated with heparin- 
papaverine solution (60 mg papaverine plus 2000 
units heparin in 500 ml of balanced salt solution, not 
Ringer's lactate, chilled to 4 ° C) and maintained in
the distended state.18 Angioscopy isroutinely used to 
directly observe valvulotomy in the nonreversed 
portion of the graft and to evaluate the overall quality 
of the graft. Angioscopes measuring an outer diam- 
eter of 1.4 to 2.2 mm are introduced through an 
irrigation sheath (Olympus Corporation, Lake Suc- 
cess, N.Y.), and all studies are videotaped for later 
evaluation. For valvulotomy a standard Mill's valvu- 
lotome is used (Pilling Inc., Fort Washington, Pa.). 
Areas of inferior quality displaying webbing, throm- 
bus, or wall sclerosis are either discarded or "up- 
graded" with patch plasties or angioscopically guided 
removal and cutting of the endoluminal obstructions 
with the MiU's valvulotome, as described previ- 
ously) 7 The graft is oriented according to the size of 
the vein. The basilic vein is usually larger in diameter 
and therefore ismost often used as the proximal and 
nonreversed part of the graft. 
In addition to length and diameter of the graft, 
the overall quality of the vein graft by angioscopic 
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Table III. Vein graft configuration and quality of the conduit as judged with angioscopy at the 
final inspection in 54 upper arm vein loop grafts 
Conduit quality 
No. Good Upgraded Inferior 
Upper arm loop 38 22 I4 2 
Upper arm loop with splicing ~ 11 2 8 1 
Upper arm loop + other arm vein 3 1 1 1 
Upper arm loop + leg vein __2 2 - - 
Total 54 27 23 4 
*Upper arm loop graft alone with onlay patch plasty, excision, and reanastomosis. 
means was noted. The frequency and localization of 
endoluminal disease and the subsequent surgical 
decisions were also noted. 
Follow-up data were collected from the indi- 
vidual surgeon's office. A graft was regarded patent 
when a graft pulse was palpable on physical exami- 
nation. Primary patency was defined as the undis- 
turbed patency without any further intervention. 
Overall graft patency and patency rates in sub- 
groups were calculated by the life-table method as 
recommended by the Ad Hoc Committee on Re- 
porting Standards appointed by the Society of 
Vascular Surgery and the North American chapter of 
the International Society of Cardiovascular Sur- 
gery. 19 Life-tables were prepared by use of the 
method of Kaplan-Meier 2°in accordance with graft 
survival. Life-tables were tested for equality by use of 
a log-rank test. 
RESULTS 
The clinical details of the 50 patients who 
underwent 54 procedures with an upper arm vein 
loop graft are summarized in Table I. The mean age 
was 69.2 years, ranging from 36 to 86 years. 
Seventy-four percent of the patients had diabetes (37 
of 50). Bilateral procedures were performed in four 
patients. The indication for surgery was limb threat- 
ening ischemia in 53 and claudication in one. 
Seventeen reconstructions were primary procedures 
(31.5%), 35 were reoperations (64.8%), and two 
were revision procedures for failing femoropopliteal 
saphenous vein grafts. 
The indication for the use of the upper arm vein 
graft is shown in Table II. The ipsilateral saphenous 
vein was unavailable as an autogenous vein graft 
because of previous use for infrainguinal bypass 
surgery in 35 of 54 (64.8%), and previous vein 
harvest for coronary artery bypass grafting in 14 
(25.9%). In five cases the ipsilateral saphenous vein 
was inadequate for use as a conduit after unroofing, 
either because of insufficient length (two of five) or 
vein quality (three of five). The contralateral saphe- 
nous vein was present as an alternative conduit in 
only 20 cases (37%). In the other 34 procedures the 
contralateral saphenous vein was unavailable ither 
because of previous use as a conduit for infrainguinal 
bypass in 26 procedures and for coronary artery 
bypass grafting in five, or it was unavailable because 
of previous saphenous vein stripping in two and 
because of below-the-knee amputation i one. 
The graft configuration and the quality of the 
conduit, as judged with angioscopy, is displayed in 
Table III. In 49 instances (90.7%, 49/54) the upper 
arm loop graft provided sufficient length to reach the 
distal target vessel. Splicing of the loop graft or partial 
patch plasty had to be performed in 11 of these cases 
(11/49, 22.5%). In five cases (five of 54, 9.3%) 
additional pieces of vein were required to lengthen 
the loop graft. Segments of arm vein were used in 
three cases, and vein segments from the leg were used 
in two, lesser saphenous vein in one, and a remnant 
of ipsilateral greater saphenous vein in the other. 
Angioscopy of the vein grafts revealed 27 grafts of 
good quality (27 of 54, 50%) without any further 
need for intervention. Twenty-seven grafts (27 of 54, 
50%) displayed endoluminal bnormalities and re- 
quired correction, such as cutting webs and strands 
with the valvnlotome under angioscopic guidance. In 
23 of these grafts (23 of 54, 42.6%) angioscopy after 
correction of the abnormalities showed asufficiently 
"upgraded" graft. In four cases (4 of 54, 7.4%), 
despite upgrading, segments of inferior quality had 
to be included in the graft. Thus 85.2% (23 of 37) of 
the grafts with initially inferior segments could be 
upgraded with angioscopically directed interven- 
tions. Abnormal segments of vein were discarded 
whenever possible or corrected. Segments of inferior 
quality were only included, when no other vein 
conduit could be obtained easily, and graft length was 
the main concern. In three cases, the upper arm vein 
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Fig. 1. Primary and secondary (corrected) patency rates of 54 upper arm loop grafts in 50 
patients. Numbers give grafts at risk, and numbers in parenthesis give SEM. 
loop provided the last possible source of autologous 
graft, in the fourth contralateral ischemia prevented 
vein harvest of the contralateral leg. 
The quality of the "simple" loop grafts was 
regarded good at angioscopic inspection in 57.9% 
(22 of 38). Of the vein grafts 36.8% (14 of 38) were 
regarded as well "upgraded," and in 5.3% (2 of 38) 
inferior segments of vein had to be included in the 
graft, despite upgrading. 
In grafts with venovenostomies or patch plasty 
(n = 16), graft quality was regarded good at final 
inspection i  31.25% (5 of 16) and 56.25% (9 of 16) 
contained upgraded segments. In 12.5% (n = 2) of 
these grafts, angioscopy inferior quality segments had 
to be included in the final graft. 
Late complications attributable to the vein har- 
vest were observed in five patients (10%). Pain in the 
arm and swelling were seen in two patients each. One 
patient was admitted with numbness in the cubital 
and volar forearm region. All patients but one who 
required local nerve blockade could be treated 
conservatively. 
Of those 20 patients in whom the contralateral 
saphenous vein was available at the time of arm vein 
harvest and salvaged, six required istal bypass on the 
contralateral leg within the time of follow-up. 
The graft anatomy is displayed in Table IV. 
Thirteen femoropopliteal grafts were constructed, of
which 12 were infrageniculate and one was supragen- 
iculate. Twenty-nine grafts were constructed to the 
tibial level. The distal outflow vessel was the anterior 
tibial artery in 14, the posterior tibial artery in seven 
and the peroneal artery in eight. Ten grafts were 
constructed to the pedal arteries, seven of which 
originated at the popliteal evel and three at the 
femoral evel. Two outflow jump grafts were per- 
formed, both originating from the midportion of an 
"old" femoropopliteal saphenous vein graft and 
reaching distally to the tibioperoneal trunk in one and 
to the peroneal artery in the other. 
Early (< 30 days) primary graft patency was 
92.6% (n = 4 occlusions) for all grafts and is shown 
in Table IV. One femoropopliteal graft failed (pri- 
mary patency femoropopliteal grafts: 92.3%), and 
one of the femorotibial grafts failed (primary patency 
for tibial grafts: 96.6%). Of the pedal grafts two 
failed (primary patency for pedal grafts: 80%). One 
of the failed grafts was revised successfully by 
thrombectomy (secondary, corrected early patency 
rate: 94.4%). None of the patients died within the 
postoperative p riod (_ 30 days) or the hospital stay. 
Four patients died during follow-up on the 
159th, 274th, 693th, and 745th postoperative day, 
respectively. The cumulative graft patency is shown 
in Fig. 1. At 1 year the primary cumulative primary 
graft patency rate was 74.4% for all grafts, and the 
secondary patency rate was 80.1%, as shown in Fig. 
1. There is no difference between primary and 
secondary patency at 1 year. In primary surgery 
uncorrected patency at 1 year was 85.7%, compared 
with 68.7% for redo and revision surgery. The 
difference is not statistically significant ~ = 0.62). 
The cumulative limb salvage rate at 1 year was 
90.7%. 
Additional subgroup analysis was undertaken to
demonstrate he significance of angioscopy findings 
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Table IV. Graft anatomy and early 
( < 30-day) primary patency rate in 54 upper 
arm vein loop graft procedures 
No. Patency (%) 
Femoropopliteal 13 12/13 (92.3) 
Above-knee 1 1/1 
Below-knee 10 9/10 
Tibioperoneal trunk 2 2/2 
Femorotibial 29 28/29 (96.5) 
Anterior tibial 14 14/14 
Posterior tibial 7 6/7 
Peroneal 8 9/9 
Femoropedal 3 2/3 (66.6) 
Popliteal-distal 7 6/7 (85.7) 
Outflow jump graft 2 2/2 (100) 
Total 54 50/54 (92.6) 
in the vein grafts. Comparison of these small 
subgroups howed that there was no statistically 
significant difference in primary patency at I year 
between vein grafts regarded as of good quality, 
without he need of upgrading, yielding 77.1%, and 
vein grafts that had been "upgraded" with no further 
abnormalities present on angioscopic examination, 
yielding 74.6% (p = 0.21). 
DISCUSSION 
Our study shows that the use of the upper arm 
vein loop graft is not only technically feasible but also 
yields acceptable 1-year patency rates. Upper arm 
veins are often usable, even in the absence of adequate 
forearm veins and therefore the combined composite 
graft is an attractive alternative arm vein graft 
allowing limb salvage in otherwise difficult circum- 
stances. Angioscopy allows additional assessment of
vein quality and has been proven to be an important 
tool to guide valve lysis and to "upgrade" the quality 
of inferior vein segments, increasing otherwise unfa- 
vorable patency rates. The upper arm veins are easily 
accessible, and few complications have been seen after 
vein harvest in the upper arm other than hypoesthesia 
after cutaneous nerve injury. The contralateral saphe- 
nous vein was available as an alternative conduit in 
less than 40% of our patients. About 48.2% had 
undergone previous bypass procedures on the con- 
tralateral limb. Subsequent revascularization f r isch- 
emia of the contralateral limb with the salvaged 
saphenous vein was necessary during follow-up in 
one third of these cases. 
The saphenous vein has been proven in numerous 
reports to be the graft of choice in distal revascular- 
ization. 4 Yet the problem of distal bypass in the 
absence of a suitable ipsilateral vein still remains a 
matter of discussion. An "all autologous reconstruc- 
tion" policy has generally been advocated, although 
there has been some support for polytetrafluoroeth- 
ylene (PTFE) or biologic graft materials under select 
conditions. 2,3,2~022 Several sources suggest hat the 
high standards of primary saphenom vein bypass 
grafting for distal revascularization cannot be met by 
alternative autologom vein sources, and therefore the 
use of artificial and biologic grafts is justified. 21'22 In 
primary reconstructive surgery PTFE has been 
shown to be inferior to saphenous vein grafts in a 
prospective randomized trial? Secondary distal by- 
pass reconstructions with PTFE leads to primary 
patency rates of 62% and revised patency rates of 
72%. 21 Reports with glutaraldehyde-stabilized um- 
bilical vein grafts 22 show similar primary success 
rates. Alternative autologous vein grafting is often 
tedious and time consuming, but it still yields better 
long-term results. 4 Series with autologous secondary 
vein grafting of different vein sources have been 
reported with primary patency rates of 76% at 1 
year.2a 
Many authors prefer the use of the contralateral 
saphcnous vein or the lesser saphenous vein in the 
first place became of the greater wall thickness as 
compared with arm vein, the availability, and ease of 
handling. 4,6,7,2a In this series of patients, the option of 
a bypass with the contralateral saphenous vein was 
present because alternative conduit was given in less 
than 40%. Six of the remaining 20 patients, in whom 
the contralateral saphenom vein was salvaged, re- 
quired distal bypass on the contralateral leg within 
the follow-up period. 
The use of arm veins as autologous conduit 
remains controversial because of the thinner vein 
wall, especially in the cephalic vein, the obtainable 
graft length, and graft diameter. With the vein graft 
co~ffiguration, herein, valve lysis is necessary. Other- 
wise a venovenostomy would be necessary to create 
a full length reversed graft. Valve lysis in partially 
reversed-nonreversed translocated saphenous vein 
grafts has been shown to cause no adverse ffects and 
has been used successfnlly. 24 
Early reports dealing with the cephalic vein 
bypass have shown that, despite their thin walls, arm 
veins are capable of withstanding arterialization a d 
high endoluminal pressures. 8n Despite reports on 
late Observations showing an increased rate of aneu- 
rysm formation attributed to less wall strength of arm 
vein grafts, 25 other series showed no increased 
aneurysmal wall degeneration, n Small vein diameter 
in the forearm led to the idea that creation of 
arteriovenous fi tulas would augment the diameter of 
the cephalic vein and increase vein utilization 
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rates. 13'26 However, vein diameter of the upper arm 
vein loop graft in our study was always ufficient, and 
an arteriovenous fi tula was not used. 
Obtaining enough graft length is always a matter 
of concern, when the veins of the arm are used. The 
upper arm vein loop graft provided enough length 
for distal bypass in 90.7% of the cases. In 22.4% an 
inferior part of the upper arm loop had to be 
discarded, and splicing of the graft had to be 
performed, but without necessitating the procure- 
ment of additional vein. In only five cases additional 
vein material was necessary to complete the bypass. 
Therefore the upper arm vein loop in our experience 
provides enough graft length for most reconstructive 
procedures, even for femorotibial and femoropedal 
reconstructions, which were performed in 59.3% in 
this series. 
Harvesting both subcutaneous pper arm veins 
had no adverse ffect o the venous drainage of the 
arm in most of our patients. Swelling of the forearm 
was seen only twice (4%). Pain of the harvest site or 
numbness as a result of cutaneous nerve trauma was 
seen in three patients (6%). No wound infection has 
been seen, or any limb-threatening complication. All 
patients but one were treated successfully with 
conservative means. In comparison to the morbidity 
of saphenous vein harvest incisions on the leg, these 
complications were regarded as minor. 
Four of the 54 grafts failed within 30 days. The 
primary early ( < 30 days) patency rate was 92.6%. 
One of the failed grafts was revised successfully 
(revised patency rate of 94.4%). Three of those four 
grafts were regarded as of inferior quality and had 
required splicing. The primary cumulative graft 
patency rate at 1 year was 74.4% for all loop grafts, 
and the revised patency rate at 1 year was 80.1%. 
Primary patency and revised, secondary patency rates 
did not differ statistically significant in our study. 
This may be attributed to the fact that revision in 
failed arm vein bypass grafts are seldom undertaken, 
because these procedures are often regarded as last 
attempts for revascularization after numerous previ- 
ous reconstructive surgeries. Grafts inserted for 
primary revascularization procedures showed 85.7% 
cumulative patency at i year, compared with 68.7% 
for redo procedures. In this regard our reported series 
of upper arm vein loop grafts does not differ from 
previously reported series of arm vein grafts as well, 
but longer follow-up will be necessary to obtain 
information on the performance of this graft com- 
pared with other arm vein grafts. 11,13 
Angioscopy is being used in all of our arm vein 
bypass grafts and has an important effect on the 
success of the upper arm vein loop graft. It has 
become an important adjunct to assess the overall 
quality of arm vein bypass grafts, 16 to  guide valve 
lysis, 27 and to "upgrade" inferior vein segments. 17
Clinical interventions according to angioscopy find- 
ings included marking out inferior segments to be 
discarded, marking the extent of patch plasties or to 
guide the disruption of endoluminal bands and 
strands. Previous reports have shown that trauma 
caused by puncture and areas of recanalization are 
frequent in arm veins. 11,17 Routine angioscopic 
assessment of arm veins has demonstrated a fre- 
quency of up to 60% of abnormal endoluminal 
findings in arm veins, which is considerably more 
than in saphenous veins, where a rate of 12% is 
reported. 283° It has been suggested that, despite 
upgrading of veins, patency of upgraded grafts will 
remain inferior to normal vein grafts. 3° In our 
previously reported experience, "upgrading" inferior 
arm vein segments led to an improved patency of 
these grafts, compared with "inferior" vein grafts. 17 
Upgraded segments were included in 42.6% of the 
loop grafts. "Upgraded" inferior loop grafts showed 
the same patency at 1 year as "normal" grafts. Vein 
grafts that required venovenostomies were of worse 
quality, compared with vein grafts without veno- 
venostomies. In further subgroup analysis the pres- 
ence of a venovenostomy seemed to have an adverse 
affect on primary patency of the vein grafts. If no 
venovenostomy had to be performed, the primary 
patency rate was 79.2%. With splicing the primary 
patency rate was 58.8%. But on further evaluation we 
could demonstrate hat vein grafts, which required 
splicing were of worse qualit-y, as regarded with 
angioscopy, than vein grafts with no splicing. With 
regard to the small number of grafts in each group, 
no significant difference between spliced and un- 
spliced grafts could be demonstrated. Most often the 
median cubital vein showed scarring caused by 
previous puncture, or "webbing" caused by recana- 
lization after thrombosis, associated with previous 
use as an intravenous access. 
In our experience the upper arm vein loop graft 
is a reliable source of vein for autologous distal 
grafting, even in the presence of absent forearm 
veins. Preoperative vein mapping with duplex scan- 
ning or venography has been undertaken infre- 
quently and has not been superior to clinical ex- 
amination. Careful angioscopic assessment deems it 
necessary to obtain results close to saphenous vein 
grafts. Creating a partially reversed-nonreversed 
vein graft does not affect patency rates, compared 
with other, previously reported series. Additional 
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surgical intervent ions to increase the availabil ity o f  
the graft have not  been necessary, at least in our  
experience. 
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DISCUSSION 
Dr. Enrico Ascer (Brooklyn, N.Y.). It is exciting to 
wimcss that, more than 4 decades after Kunlin used a 
saphenous vein graft to revascularize an ischemic lower 
extremity, wc continue to devclop new techniques and 
undercover new sources of autogenous material in an 
attempt to expand our indications for limb salvage surgery. 
The New England Deaconess group reports on the early 
and midterm results of infrainguinal arterial bypasses 
performed with superficial veins of the arm, more specifi- 
cally the basilic-cephalic loop segment, a technique de- 
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scribed earlier by Frank LoGerfo. This study also reem- 
phasizes the value ofintraoperative angioscopy to assess the 
adequacy of these veins as bypass conduits. 
I must highlight he relatively small number of cases 
and the limited follow-up of this study. Mthough the 
1-year patency rate for all grafts is almost 75%, the authors 
have chosen to group both popliteal and infrapopliteal 
bypasses into one life-table analysis, although this com- 
parison with other available alternatives i not feasible. 
Almost 40% of these patients had a contralateral 
greater saphenous vein that could have been used as a 
bypass conduit. Taking into consideration that many of 
these patients had already experienced at least one bypass 
failure, I ask Dr. H61zenbein to comment on his indications 
to forsake the use of the contralateral greater saphenous in
favor of this new procedure. Could you also comment on 
your policy regarding the use of the lesser saphenous vein? 
The median communicating vein is probably the most 
traumatized vein of all by repeated punctures, and it is not 
surprising that close to 30% of your cases required repair 
or splicing. Could you have minimized the dissection and 
saved time by using preoperative duplex ultrasonography 
to better assess these veins? How often was the basilic- 
cephalic loop deemed unusable, which led you to abandon 
this procedure? 
We have previously shown that long reversed saphe- 
nous veins did not fare well in presence of a disadvantaged 
outflow tract. Have you noticed a similar trend with arm 
veins? 
Because it has been well documented by several 
investigators that a significant number of saphenous vein 
grafts will develop stenotic lesions that can be detected and 
repaired before bypass failure, I am interested in learning 
about the incidence of such failing grafts in your series. 
Moreover, arm veins can become aneurysmal. Have you 
noticed any obvious diameter expansion of your grafts 
during the follow-up period? 
Dr. Sladen from Canada has reported on a similar 
technique by use of graft made from basilic and brachial 
veins. Would you consider this to be a viable option to 
acquire more vein length and avert splicing? 
I must refrain from advocating the superiority of the 
basilic-cephalic vein loop when compared with other more 
standard alternatives tothe ipsilateral saphenous vein. I will 
be convinced otherwise if more patients and longer 
follow-up are presented with in&pendent life-table analysis 
for popliteal and infrapopliteal bypasses. More appropri- 
ately, a prospective randomized study will go a long way in 
establishing this new vein graft as a must in the armamen- 
tarium of the vascular surgeon. The alternative grafts to be 
compared with the basilic-cephalic loop vein should 
include the lesser saphenous vein and prosthetic graft with 
or without adjunctive arteriovenous fi tulas. 
Dr. Thomas J. H61zenbein. The contralateral saphe- 
nous vein is present only in 40% of our patients. In the 
other patients this option was not available. Within the 
period of follow-up, which is rather short, one third of 
these patients required distal bypass with use of the 
preserved contralateral saphenous vein. Regarding the 
lesser saphenous vein, we used the lesser saphenous vein 
infrequently. Our policy is to use the arm veins in the first 
place as a secondary graft of choice. Preoperative duplex 
scanning is undertaken infrequently and has not been 
proven in our hands to be superior to clinical examination. 
Regarding the expanding diameter, this has not been 
observed in our series. We had only one failing graft, which 
was repaired. Therefore the secondary graft patency rate is 
not significantly better than the primary graft patency rate. 
Regarding the difference between popliteal and infrapop- 
liteal grafts, only one graft of the series was above the knee. 
All the other grafts are to below-the-knee or pedal arteries. 
So I think it was justifiable to put all these grafts together 
in one life-table. 
Dr. Harry L. Bush, Jr. (New York, N.Y.). Please 
clarify for me whether you make one or two incisions in the 
upper arm. 
Dr. H61zenbein. Two separate incisions are made with 
bridge left in the cubital fossa. 
Dr. Bush. Do you ever use part of the cephalic vein 
distally in the forearm? Do you use that as a splice segment 
to extend the length of the graft so you can actually reach 
the pedal evel? You had a couple of grafts that were femoral 
pedal grafts. Clearly, the length was not adequate just from 
your loop. How do you manage that? 
Dr. H61zenbein. If we need additional vein we try 
to use only one extremity. To lengthen the loop graft in 
three of our five cases, additional arm vein was used. The 
cephalic vein is always used. In two it was used as patch 
angioplasty. A short interposition segment can be used 
if the median cubital vein is unusable. 
Dr. Jack L. Cronenwett (Lebanon, N.H.). Your 
results are enviable, even though they may be short-term 
follow-up. Is it important to use the cephalic and basilic 
vein as a continuous loop? Can we tall from your data 
whether the addition of a venous venostomy in the 
midpoint is really detrimental? It has been our experience 
that, even with the use of angioscopy, we have had more 
difficulty with valve lysis in the arm veins. We therefore 
tried to use them in a reversed fashion to avoid having to 
perform valve lysis and have preferred to do the venovenos- 
tomy. I am not sure from your data whether I can conclude 
that our approach is wrong. Can you convince me that it 
is better to use the arm vein in one total segment? 
Dr. H61zenbein. The proximal level of the basilic vein 
is very big in diameter, usually more than 1 cm. So we think 
it is pretty difficult o reverse the graft, having the huge vein 
at the distal end where the artery is small. We think it is a 
rather convenient graft. The proximal anastomosis i  very 
easy with a big basilic vein. We have experience with valve 
lysis using in situ grafts and the nonreversed saphenous vein 
grafts. We have never experienced any problems with valve 
lysis in the loop grafts. 
Dr. Kent. After reading your original report a few 
years ago, I tried this technique several times. Unfortu- 
nately we do not have the capabilities of performing 
preoperative scanning, nor have I ever figured out how to 
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run one of those angioscopes. I have gotten burned a 
couple of times because the median cubital vein is stenotic 
in my intraoperative angiogram. Is there another way to 
figure this out ahead of time? 
Dr. H61zenbein. We have used duplex scanning in a 
couple of cases. But usually we didn't perform duplex 
scanning, and our judgment was based most often on 
intraoperative exploration of the vein. Of course, we had to 
perform some kind of upgrading in the location of the 
median cubital vein. Upgrading included lysis of the webs, 
onlay patch angioplasty, or even discarding this segment. 
Dr. John J. Ricotta (Buffalo, N.Y.). Do you use this 
loop in preference to a single continuous egment of 
cephalic vein? Is this your preferred approach, or, if you had 
a good long cephalic vein from the wrist to the shoulder, 
would you use that? 
Dr. H61zenbein. We use arm veins quite frequently. 
We don't use this graft preferentially. We also use the 
cephalic vein preferentially. We use the loop graft only if the 
forearm vein seems not to be useable for distal bypass. 
Dr. Ricotta. How do your patients tolerate this? The 
few times that I have done this, the patients have not been 
particularly happy about either the cosmetic result or this 
long incision. Also for some reason, maybe because of the 
activity of the upper arms, they seem to have more 
morbidity than from lower extremity incisions. 
Dr. H61zenbein. We have only five complications in
the series. Most of them are related to nerve injury. Only 
two of them had swelling, and we never had any wound 
infections. All patients except one underwent operation for 
limb salvage. So I think we can tolerate these minor 
complications. 
